Self-reported quality of life measure is reliable and valid in adult patients suffering from schizophrenia with executive impairment

Schizophrenia Research

Volumn 147, Issue 1, 2013, Pages 58-67

  Baumstarck, Karine ^a   Boyer, Laurent ^a   Boucekine, Mohamed ^a   Aghababian, Valérie ^b   Parola, Nathalie ^c   Lançon, Christophe ^c   Auquier, Pascal ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b University of Provence Aix Marseille University   (France)

^c HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Executive dysfunction; Quality of life; Reliability; Schizophrenia; SQoL18; Validity

Indexed keywords

ADULT; ARTICLE; ATTENTION; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE DURATION; EXECUTIVE FUNCTION; EXTERNAL VALIDITY; FACTORIAL ANALYSIS; FEMALE; HUMAN; INTERNAL VALIDITY; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL PERFORMANCE; OUTCOME ASSESSMENT; PATIENT CODING; POPULATION RESEARCH; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; RELIABILITY; SCHIZOPHRENIA; SCORING SYSTEM; SELF REPORT; VALIDATION PROCESS;

ADULT; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SELF REPORT; YOUNG ADULT;

EID: 84877155872     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.03.008     Document Type: Article

References (43)

1. Addington D., Addington J., Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression Scale. Br. J. Psychiatry 1993, (Suppl. 22):39-44.
2. APA DSM-IV. Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Washington, DC, (Text revised). 4th ed.
3. Auquier P., Simeoni M.C., Sapin C., Reine G., Aghababian V., Cramer J., Lancon C. Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia: the S-QoL. Schizophr. Res. 2003, 63(1-2):137-149.
4. Baumstarck K., Pelletier J., Aghababian V., Reuter F., Klemina I., Berbis J., Loundou A., Auquier P. Is the concept of quality of life relevant for multiple sclerosis patients with cognitive impairment? Preliminary results of a cross-sectional study. PLoS One 2012, 7(1):e30627.
5. Baumstarck K., Reuter F., Boucekine M., Aghababian V., Klemina I., Loundou A., Pelletier J., Auquier P. Relevance of Quality of Life assessment for multiple sclerosis patients with memory impairment. PLoS One 2012, 7(12):e50056.
6. Bell M., Fiszdon J., Richardson R., Lysaker P., Bryson G. Are self-reports valid for schizophrenia patients with poor insight? Relationship of unawareness of illness to psychological self-report instruments. Psychiatry Res. 2007, 151(1-2):37-46.
7. Benton A.L., Hamsher K., Sivan A.B. Multilingual aphasia examination 1976, University of Iowa, Iowa City, IA.
8. Berzon R., Hays R.D., Shumaker S.A. International use, application and performance of health-related quality of life instruments. Qual. Life Res. 1993, 2(6):367-368.
9. Boyer L., Simeoni M.C., Loundou A., D'Amato T., Reine G., Lancon C., Auquier P. The development of the S-QoL 18: a shortened quality of life questionnaire for patients with schizophrenia. Schizophr. Res. 2011, 121(1-3):241-250.
10. Boyer L., Aghababian V., Richieri R., Loundou A., Padovani R., Simeoni M.C., Auquier P., Lancon C. Insight into illness, neurocognition and quality of life in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 36(2):271-276.
11. Bureau-Chalot F., Novella J.L., Jolly D., Ankri J., Guillemin F., Blanchard F. Feasibility, acceptability and internal consistency reliability of the nottingham health profile in dementia patients. Gerontology 2002, 48(4):220-225.
12. Christopher M.E., Miyake A., Keenan J.M., Pennington B., Defries J.C., Wadsworth S.J., Willcutt E., Olson R.K. Predicting word reading and comprehension with executive function and speed measures across development: a latent variable analysis. J. Exp. Psychol. Gen. 2012, 141(3):470-488.
13. Cronbach L.J. Coefficient alpha and the internal structure of tests. Psychometrika 1951, 16:297-334.
14. DePalma J.A. Measuring quality of life of patients of traumatic brain injury. Crit. Care Nurs. Q. 2001, 23(4):42-51.
15. Elvevag B., Goldberg T.E. Cognitive impairment in schizophrenia is the core of the disorder. Crit. Rev. Neurobiol. 2000, 14(1):1-21.
16. Finlay W.M., Lyons E. Methodological issues in interviewing and using self-report questionnaires with people with mental retardation. Psychol. Assess. 2001, 13(3):319-335.
17. Gee L., Pearce E., Jackson M. Quality of life in schizophrenia: a grounded theory approach. Health Qual. Life Outcomes 2003, 1:31.
18. Godefroy O. Fonctions executives et pathologies neurologiques et psychiatriques. Evaluation en pratique clinique 2008, et le Groupe de Reflexion pour l'Evaluation des Fonctions EXécutives (GREFEX), Collection neuropsychologie, Marseille, France. Solal (Ed.).
19. Gold S.M., Schulz H., Monch A., Schulz K.H., Heesen C. Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures. Mult. Scler. 2003, 9(4):404-410.
20. Green M.F., Kern R.S., Heaton R.K. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr. Res. 2004, 72(1):41-51.
21. Hoe J., Katona C., Roch B., Livingston G. Use of the QOL-AD for measuring quality of life in people with severe dementia-the LASER-AD study. Age Ageing 2005, 34(2):130-135.
22. Jensen A.R. Scoring the Stroop test. Acta Psychol. (Amst) 1965, 24:398-408.
23. Juniper E.F., Guyatt G.H., Mesbah M., Ravaud P. Quality of life and pharmacoeconomics in clinical trials 1996, Lippincott-Raven, Philadelphia.
24. Kay S.R., Opler L.A., Fiszbein A. Significance of positive and negative syndromes in chronic schizophrenia. Br. J. Psychiatry 1986, 149:439-448.
25. Knaüper B., Belli R.F., Hill D.H., Herzog A.R. Question difficulty and respondents' cognitive ability: the effect on data quality. J. Off. Stat. 1997, 13(2):181-199.
26. Manning V., Wanigaratne S., Best D., Strathdee G., Schrover I., Gossop M. Screening for cognitive functioning in psychiatric outpatients with schizophrenia, alcohol dependence, and dual diagnosis. Schizophr. Res. 2007, 91(1-3):151-158.
27. Marrie R.A., Miller D.M., Chelune G.J., Cohen J.A. Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis. Mult. Scler. 2003, 9(6):621-626.
28. McKenna S. Measuring quality of life in schizophrenia. Eur. Psychiatry 1997, (12):267s-274s.
29. Minzenberg M.J., Laird A.R., Thelen S., Carter C.S., Glahn D.C. Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch. Gen. Psychiatry 2009, 66(8):811-822.
30. Nishiyama T., Ozaki N. Measurement limit of quality-of-life questionnaires in psychiatric settings. Qual. Life Res. 2010, 19(1):25-30.
31. Nunnaly J.C., Bernstein I.C. Psychometric theory 1994, Mc Graw-Hill, New York.
32. Orley J., Saxena S., Herrman H. Quality of life and mental illness. Reflections from the perspective of the WHOQOL. Br. J. Psychiatry 1998, 172:291-293.
33. Patrick D.L., Deyo R.A. Generic and disease-specific measures in assessing health status and quality of life. Med. Care 1989, 27(Suppl. 3):S217-S232.
34. Prince P.N., Gerber G.J. Measuring subjective quality of life in people with serious mental illness using the SEIqoL-DW. Qual. Life Res. 2001, 10(2):117-122.
35. Reine G., Simeoni M.C., Auquier P., Loundou A., Aghababian V., Lancon C. Assessing health-related quality of life in patients suffering from schizophrenia: a comparison of instruments. Eur. Psychiatry 2005, 20(7):510-519.
36. Reitan R.M. Validity of the Trail Making Test as an indicator of organic brain damage. Percept. Mot. Ski. 1958, 8:271-276.
37. Riemsma R.P., Forbes C.A., Glanville J.M., Eastwood A.J., Kleijnen J. General health status measures for people with cognitive impairment: learning disability and acquired brain injury. Health Technol. Assess. 2001, 5(6):1-100.
38. Rosen W.G. Verbal fluency in aging and dementia. J. Clin. Neuropsychol. 1980, 2:135-146.
39. Szoke A., Trandafir A., Dupont M.E., Meary A., Schurhoff F., Leboyer M. Longitudinal studies of cognition in schizophrenia: meta-analysis. Br. J. Psychiatry 2008, 192(4):248-257.
40. Voruganti L., Heslegrave R., Awad A.G., Seeman M.V. Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability. Psychol. Med. 1998, 28(1):165-172.
41. Ware J.E., Harris W.J., Gandek B. MAP-R for Windows: Multitrait-Multi-Item Analysis Program-Revised User's Guide 1997, Health Assessment Lab., Boston.
42. Wong J.G., Cheung E.P., Chen E.Y., Chan R.C., Law C.W., Lo M.S., Leung K.F., Lam C.L. An instrument to assess mental patients' capacity to appraise and report subjective quality of life. Qual. Life Res. 2005, 14(3):687-694.
43. Wright B., Linacre J., Chicago I. Winsteps: A Rasch Model Computer Program, Version 3.31 2001, MESA Press.